Opdyta (PAP) 40mg Injection

Short Description

Opdyta (PAP) 40mg Injection is used to treat various types of cancer, including non-small cell lung cancer, kidney cancer, head and neck cancer, melanoma, Hodgkin's disease, and liver cancer.

Dosage Form

Injection

Introduction

Opdyta (PAP) 40mg Injection is given as an infusion into a vein by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Your doctor or nurse will give you this medicine. Kindly do not self-administer.

Side Effects

Rash Weakness Headache Fever Chills or shaking Itching Rash Flushing Difficulty breathing Dizziness

Breastfeeding Warning

This medicine is not recommended during breastfeeding. Use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Pregnancy Warning

This medicine is not recommended during pregnancy. Use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Opdyta (PAP) 40mg Injection is an anti-cancer medication. It works by blocking a protein (PD-1) on the surface of certain immune cells called T-cells. This action activates the T-cells to locate and kill cancer cells.

Given as an injection or infusion under the supervision of a doctor only Do not skip any dose and complete the course as suggested by your doctor Use an effective method of birth control to avoid pregnancy while taking this medication Your doctor may get regular blood tests done to monitor your blood cell count (CBC), electrolyte levels, liver and kidney function Inform your doctor if you experience fever, chills, rash, and shortness of breath during the treatment